FDA Logo U.S. Food and Drug AdministrationCenter for Food Safety and Applied Nutrition
 U.S. Department of Health and Human Services

FDA Home Page | CFSAN Home | Search/Subject Index | Q & A | Help

horizontal rule

August 2008

horizontal rule

2008 Cardiovascular Biomarkers and Surrogate Endpoints Symposium

BUILDING A FRAMEWORK FOR BIOMARKER APPLICATION

September 10-12, 2008
Bethesda North Marriott
Hotel & Conference Center
Bethesda, Maryland

Registration Deadline: September 8, 2008

Program and Registration

Registration, abbreviated agenda, and additional information is available in PDF.
Full agenda is available in PDF.

CO-CHAIRS

Peter Libby, M.D.
Chief, Cardiovascular Medicine
Brigham and Women's Hospital

Jean-Claude Tardif, M.D.
Director
Montreal Heart Institute Research Center

Objectives:

  • Examine surrogate endpoints and controversies regarding their use in cardiovascular and diabetes drug approvals
  • Review the latest biomarker and imaging technology data from recently completed clinical trials
  • Identify best practices for biomarker assessment and validation
  • Build a framework for biomarker application in research, development, clinical practice and public health

This meeting is co-sponsored by:

BWH - Brigham and Women's Hospital, A teaching affiliate of Harvard Medical School NHLBI - National Heart Lung and Blood Institute, People Science Health
CMOD - International Partnership for Critical Markers of Disease
U.S. Department of Health and Human Services
U.S. Food and Drug Administration
Center for Food Safety and Applied Nutrition
MHICC - Montreal Heart Institute Coordinating Center
horizontal rule
Food Labeling and Nutrition   |   Public Meetings
horizontal rule
CFSAN Home | CFSAN Search/Subject Index | CFSAN Disclaimers & Privacy Policy | CFSAN Accessibility/Help
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Center for Food Safety & Applied Nutrition
Hypertext updated by cjm August 12, 2008